Brick & Kyle Associates’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.26M Buy
+20,796
New +$1.21M 0.42% 44
2019
Q1
Sell
-37,957
Closed -$1.97M 67
2018
Q4
$1.97M Buy
+37,957
New +$2.04M 1.89% 19
2018
Q2
$2.23M Sell
40,369
-12,692
-24% -$685K 1.75% 22
2018
Q1
$3.36M Sell
53,061
-592
-1% -$38.1K 2.71% 8
2017
Q4
$3.29M Sell
53,653
-268
-0.5% -$16.8K 2.67% 10
2017
Q3
$3.44M Buy
53,921
+62
+0.1% +$3.62K 2.78% 8
2017
Q2
$3M Sell
53,859
-3,316
-6% -$180K 2.58% 13
2017
Q1
$3.11M Sell
57,175
-4,028
-7% -$221K 2.41% 9
2016
Q4
$3.58M Buy
61,203
+2,029
+3% +$111K 2.87% 2
2016
Q3
$3.19M Buy
59,174
+741
+1% +$47.6K 2.57% 4
2016
Q2
$4.3M Buy
58,433
+1,020
+2% +$72.1K 3.52% 1
2016
Q1
$3.67M Buy
57,413
+146
+0.3% +$9.21K 3.18% 2
2015
Q4
$3.94M Buy
57,267
+5,083
+10% +$336K 3.47% 2
2015
Q3
$3.09M Buy
52,184
+1,978
+4% +$125K 2.9% 3
2015
Q2
$3.34M Buy
50,206
+1,798
+4% +$118K 2.8% 4
2015
Q1
$3.12M Buy
48,408
+2,240
+5% +$140K 2.67% 5
2014
Q4
$2.73M Buy
+46,168
New +$2.6M 2.35% 7

Other funds holding BMY

Brick & Kyle Associates's BMY Position: Q1 2026 in Review

Brick & Kyle Associates opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 20,796 shares worth $1.26M. The stake represents 0.42% of the portfolio and ranks #44 among its holdings. This is a return to the name: Brick & Kyle Associates previously reported a position in BMY as recently as Q4 2018.

Brick & Kyle Associates first reported a position in BMY in Q4 2014 and has held it in 17 quarters since. The position peaked at $4.3M in Q2 2016. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Brick & Kyle Associates held 20,796 shares of Bristol-Myers Squibb worth $1.26M as of Q1 2026.
  • Bristol-Myers Squibb was a new Brick & Kyle Associates position in Q1 2026.
  • Bristol-Myers Squibb made up 0.42% of Brick & Kyle Associates's portfolio in Q1 2026, its #44 holding.
  • Brick & Kyle Associates first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 17 quarters since.
  • Brick & Kyle Associates's Bristol-Myers Squibb position peaked at $4.3M in Q2 2016.
  • 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Brick & Kyle Associates's 13F filing for Q1 2026, filed 2 Jul 2026.